EUVIMEDEUVIMED entdecken
Open Access

Selection of Outcomes and Measurement Methods in Clinical Trials for Digital Therapeutics: Qualitative Analysis

Johannes Mahlmann, Anne Mainz, Vera Weirauch, Achim Mortsiefer, Sven Meister

JMIR Formative Research · 15.10.2026 · 10 · e86437-e86437

DOI: 10.2196/86437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JMIR Formative Research, online erschienen am 15.10.2026. Verfasst von Johannes Mahlmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Care Informatics, Faculty of Health, School of Medicine, Witten/Herdecke University, Pferdebachstraße 11, Witten, 58448, Germany, 49 2302 9267…. Hauptthemen laut MEDLINE: Outcome Assessment, Health Care, Clinical Trials as Topic, Mobile Applications, Research Design. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In recent years, the availability of digital therapeutic apps in medicine, digital therapeutics (DTx), has significantly increased. To evaluate the therapeutic efficacy of DTx, an increasing number of scientific studies have been conducted in this field. Several authors have pointed out that a standardized approach to DTx evaluation is relevant to improving the comparability of apps in the future. Currently, it is unclear how study authors proceed when selecting outcomes and measurement methods (O&M) for DTx studies.

Objective

The primary aim of this study was to investigate how study authors currently select O&M in DTx studies, specifically for applications delivered in the form of apps. The secondary objectives were to collect suggestions for improving the comparability of DTx apps and studies in the future and to examine whether core outcome sets (COS) could represent a possible solution for enhancing comparability.

Methods

This study was based on 19 semistructured interviews. All interview partners had prior experience in planning and conducting DTx studies. The interviews were conducted between August 2024 and November 2024. Subsequently, qualitative data analysis was performed according to Kuckartz and Rädiker using a deductive-inductive research approach.

Results

The results of this study showed that the methodological approach for selecting O&M in DTx studies was primarily based on research, as well as on personal prior experience and individual ideas. Interview participants indicated that when selecting O&M, they particularly focused on aspects such as scientific quality criteria or practical implementation and feasibility. A suggestion for achieving better comparability of DTx studies in the future was to use standardized O&M per therapeutic indication area. Almost all interviewees considered COS to be a suitable approach for improving the comparability of DTx and associated studies. However, we also identified critical perspectives that questioned their application.

Conclusions

Across professional groups, both commonalities and differences were observed in methodological approaches as well as in the selection of O&M in DTx studies. To improve the comparability of DTx interventions and trials, several approaches have been developed, for example, through the use of guidance frameworks, artificial intelligence programs, or the establishment of COS. However, further research is warranted to advance this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Outcome Assessment, Health CareClinical Trials as TopicMobile ApplicationsResearch DesignHumansQualitative ResearchDigital Health

Stichwörter der Autor:innen

DTxclinical efficacy trialclinical trial methodologycore outcome setdigital health evaluationdigital health interventionsdigital therapeuticsmeasurement instrumentsmobile health appsoutcome measurementqualitative research

Autor:innen und Institutionen

  • Health Care Informatics, Faculty of Health, School of Medicine, Witten/Herdecke University, Pferdebachstraße 11, Witten, 58448, Germany, 49 2302 92678608.
  • Department of Healthcare, Fraunhofer Institute for Software and Systems Engineering, Dortmund, Germany.
  • General Practice II and Patient-Centredness in Primary Care, Institute of General Practice and Primary Care, Faculty of Health, School of Medicine, Witten/Herdecke University, Witten, Germany.

Zitieren

APA

Mahlmann, J., Mainz, A., Weirauch, V., Mortsiefer, A., & Meister, S. (2026). Selection of Outcomes and Measurement Methods in Clinical Trials for Digital Therapeutics: Qualitative Analysis. JMIR Formative Research, 10, e86437-e86437. https://doi.org/10.2196/86437

Vancouver

Mahlmann J, Mainz A, Weirauch V, Mortsiefer A, Meister S. Selection of Outcomes and Measurement Methods in Clinical Trials for Digital Therapeutics: Qualitative Analysis. JMIR Formative Research. 2026;10:e86437-e86437. doi:10.2196/86437

BibTeX
@article{Mahlmann2026,
  author = {Mahlmann, Johannes and Mainz, Anne and Weirauch, Vera and Mortsiefer, Achim and Meister, Sven},
  title = {Selection of Outcomes and Measurement Methods in Clinical Trials for Digital Therapeutics: Qualitative Analysis},
  journal = {JMIR Formative Research},
  year = {2026},
  volume = {10},
  pages = {e86437--e86437},
  doi = {10.2196/86437}
}
Kostenlos starten →